Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Silica Gel Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel acidified silica gel method for dabigatran intermediate. Reduces waste, improves purity, ensures supply chain stability for pharma manufacturing.
Patent CN108191778A reveals one pot synthesis reducing costs. Enhances supply chain reliability for high purity pharmaceutical intermediates manufacturing globally.
Patent CN108191778B enables high-purity API intermediates through simplified one-pot process, reducing costs and lead times for pharmaceutical supply chains.